MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Non-invasive, automated corneal nerve quantification reveals neurodegeneration in Parkinson’s disease: A potential novel imaging biomarker

S. Lim, M. Ferdousi, A. Kalteniece, C. Kobylecki, R. Malik, M. Silverdale (Salford, United Kingdom)

Meeting: 2018 International Congress

Abstract Number: 1414

Keywords: Parkinsonism

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Neuroimaging And Neurophysiology

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: The aim of the study is to use automated analysis of corneal confocal microscopy (CCM) images to allow rapid and reliable quantification of corneal nerve degeneration in patients with idiopathic Parkinson’s disease (IPD).

Background: One of the major challenges in Parkinson’s disease drug development is how to accurately monitor neuronal loss and hence the efficacy of new drugs. There are concerns about the sensitivity and inter- and intra-rater reliability with clinical scales such as the UPDRS. Several neuropathological studies(1) have demonstrated pathological changes in small nerve fibers in skin biopsies of patients with IPD, opening up the possibility of using measures of small fiber loss to monitor disease progression and degeneration in IPD. Whilst estimation of nerve fiber density with a skin biopsy offers an objective means of quantifying small fiber pathology, it is an invasive, time-consuming and costly procedure and not repeatable. CCM has been shown to be a valid technique to detect small fiber neuropathy non-invasively and reliably. We have previously demonstrated changes in CCM parameters in IPD patients compared to controls (2). This study uses automated analysis of CCM parameters to demonstrate a difference in small fiber nerves between IPD patients and controls

Methods: Images were analyzed using automated nerve analysis software, ACCMetrics (University of Manchester, UK), to quantify corneal nerve fiber density (CNFD), corneal nerve branch density (CNBD), corneal nerve fiber length (CNFL), corneal total branch density (CTBD), corneal nerve fiber area (CNFA) and corneal nerve fiber width (CNFW).

Results: 27 IPD patients (17 male, 10 female, mean age 64 years) and 27 controls (16 male, 11 female, mean age 60 years) were enrolled in the study. All CCM parameters except CNFW were significantly (p<0.05) lower compared to controls (CNFD mean difference: -4.062 no/mm2, p =0.049; CNBD mean difference: -12.46 no/mm2, p =0.006; CNFL mean difference: -2.89 no/mm2, p =0.008; CTBD mean difference: -17.73 no/mm2, p= 0.004; CNFA mean difference: -0.001 no/mm2, p=0.034).

Conclusions: Automated CCM analysis detects extensive small fiber damage in patients with IPD, which may allow the assessment of neurodegeneration and regeneration. We are performing a longitudinal study to assess changes in CCM parameters in patients with IPD over time.

References: 1. Donadio V, Incensi A, Leta V, Giannoccaro MP, Scaglione C, Martinelli P, et al. Skin nerve a-synuclein deposits:A biomarker for idiopathic Parkinson disease. Neurology. 2014;82(15):1362–9. 2. Kass-Iliyya L, Javed S, Gosal D, Kobylecki C, Marshall A, Petropoulos IN, Ponirakis G, Tavakoli M, Ferdousi M, Chaudhuri K, Jeziorska M, Malik R, Silverdale M. Small fiber neuropathy in Parkinson’s disease: A clinical, pathological and corneal confocal microscopy study. Park Relat Disord. 2015;21(12):1454–60.

To cite this abstract in AMA style:

S. Lim, M. Ferdousi, A. Kalteniece, C. Kobylecki, R. Malik, M. Silverdale. Non-invasive, automated corneal nerve quantification reveals neurodegeneration in Parkinson’s disease: A potential novel imaging biomarker [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/non-invasive-automated-corneal-nerve-quantification-reveals-neurodegeneration-in-parkinsons-disease-a-potential-novel-imaging-biomarker/. Accessed May 18, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/non-invasive-automated-corneal-nerve-quantification-reveals-neurodegeneration-in-parkinsons-disease-a-potential-novel-imaging-biomarker/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley